Piotr Korbal

75 Ujejskiego St
Bydgoszcz, KP 85168, Poland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

A phase 3, randomized study to evaluate the safety, tolerability, and immunogenicity of V116 in children and adolescents with increased risk of pneumococcal disease (STRIDE-13).

A phase 3, randomized study to evaluate the safety, tolerability, and immunogenicity of V116 in children and adolescents with increased risk of pneumococcal disease (STRIDE-13).

Journal: Human vaccines & immunotherapeutics

Published: June 23, 2026

Immunogenicity and safety of concomitant vaccines given with 20-valent pneumococcal conjugate vaccine in healthy infants.

Immunogenicity and safety of concomitant vaccines given with 20-valent pneumococcal conjugate vaccine in healthy infants.

Journal: Vaccine

Published: September 15, 2025

A Phase 4 Trial to Describe the Immunogenicity, Safety, and Tolerability of MenB-fHbp in Participants > 10 Years of Age With Asplenia or Complement Deficiency.

A Phase 4 Trial to Describe the Immunogenicity, Safety, and Tolerability of MenB-fHbp in Participants > 10 Years of Age With Asplenia or Complement Deficiency.

Journal: American journal of hematology

Published: August 29, 2025

Labor Matters: Thromboelastometry Shows Differences in Newborn Hemostasis.

Labor Matters: Thromboelastometry Shows Differences in Newborn Hemostasis.

Journal: Neonatology

Published: July 11, 2025

Immunogenicity and safety of an investigational varicella zoster vaccine in toddlers aged 12-15 months: results of a phase II, controlled, randomized trial.

Immunogenicity and safety of an investigational varicella zoster vaccine in toddlers aged 12-15 months: results of a phase II, controlled, randomized trial.

Journal: Vaccine

Published: June 05, 2025

Phase 3 Safety and Immunogenicity Study of a Three-dose Series of Twenty-valent Pneumococcal Conjugate Vaccine in Healthy Infants and Toddlers.

Phase 3 Safety and Immunogenicity Study of a Three-dose Series of Twenty-valent Pneumococcal Conjugate Vaccine in Healthy Infants and Toddlers.

Journal: The Pediatric infectious disease journal

Published: March 08, 2024

Immunogenicity and Safety of a Third COVID-19 BNT162b2 mRNA Vaccine Dose in 5- to 11-Year Olds.

Immunogenicity and Safety of a Third COVID-19 BNT162b2 mRNA Vaccine Dose in 5- to 11-Year Olds.

Journal: Journal of the Pediatric Infectious Diseases Society

Published: October 03, 2022

Association of Neutrophil-to-Lymphocyte Ratio and Lymphocyte-to-Monocyte Ratio with Treatment Modalities of Acute Ischaemic Stroke: A Pilot Study.

Association of Neutrophil-to-Lymphocyte Ratio and Lymphocyte-to-Monocyte Ratio with Treatment Modalities of Acute Ischaemic Stroke: A Pilot Study.

Journal: Medicina (Kaunas, Lithuania)

Published: April 29, 2019

Plasma levels of the A subunit of factor XIII in patients undergoing off-pump coronary artery bypass surgery.

Plasma levels of the A subunit of factor XIII in patients undergoing off-pump coronary artery bypass surgery.

Journal: Polish archives of internal medicine

Published: August 18, 2017

Evaluation of tissue factor bearing microparticles in the cord blood of preterm and term newborns.

Evaluation of tissue factor bearing microparticles in the cord blood of preterm and term newborns.

Journal: Thrombosis research

Published: December 23, 2016

Antenatal corticosteroids and respiratory distress syndrome - the first Polish national survey.

Antenatal corticosteroids and respiratory distress syndrome - the first Polish national survey.

Journal: Ginekologia polska

Published: July 29, 2016

STRATEGIES OF USING SURFACTANT: RESULTS OF THE FIRST POLISH NATIONAL SURVEY OF DAILY PRACTICE.

STRATEGIES OF USING SURFACTANT: RESULTS OF THE FIRST POLISH NATIONAL SURVEY OF DAILY PRACTICE.

Journal: Developmental period medicine

Published: March 10, 2016

Showing 1-12 of 15

Last Updated: 09/26/2026